AliveDx Suisse S.A. and DPC Lebanon (Diagnostic Products Corporation Lebanon Sarl) Sign Strategic Distribution Agreement in Lebanon
AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with DPC Lebanon. Under this agreement, DPC Lebanon is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions across Lebanon.
This partnership represents an important step in AliveDx’s continued expansion in the Middle East and reinforces its commitment to supporting healthcare providers with innovative and high-value diagnostic technologies. Through this collaboration, AliveDx and DPC Lebanon aim to improve access to advanced diagnostics, helping clinicians shorten time to diagnosis and enhance patient outcomes.
Transforming Diagnostics with MosaiQ® & LumiQ®
The MosaiQ® and LumiQ® platforms are designed to simplify laboratory workflows and enhance operational efficiency through fully automated, multiplex microarray assay technology. These platforms enable laboratories to deliver faster, more cost-effective, and high-quality diagnostic solutions, benefiting both healthcare professionals and patients.
“We are pleased to partner with DPC Lebanon and to expand AliveDx’s presence in Lebanon through a strong and capable local partner. This agreement reflects our commitment to bringing innovative diagnostic solutions to healthcare systems across the region,” said Manuel O. Méndez, CEO of AliveDx.
“Lebanon is an important market for AliveDx in the Levant region. Partnering with DPC Lebanon allows us to work closely with an experienced organization that understands the local healthcare landscape. We look forward to building a successful collaboration that delivers clinical and economic value to laboratories and clinicians,” said Khaled Hamed, Head of Global Emerging Markets, AliveDx.
About DPC Lebanon
DPC Lebanon (Diagnostic Products Corporation Lebanon Sarl) is a family‑owned healthcare company established in 1980. The organization originated as RIA Reference Labs after its Founder, Dr. Chamel Macaron, introduced advanced radioimmunoassay technologies to Lebanon, drawing on his extensive experience as an endocrinologist in Chicago.
With more than three decades of experience, DPC Lebanon has grown into one of the key players in the Lebanese healthcare market, supporting laboratories and hospitals with innovative diagnostic solutions spanning immunoassay, molecular diagnostics, and point‑of‑care testing. Its longstanding expertise and market leadership have led to DPC Lebanon being recognized among the Top 200 Distributors of In‑Vitro Diagnostics Products Worldwide (2nd Edition) by Research and Markets.
“We are honored to partner with AliveDx and to introduce the MosaiQ® and LumiQ® platforms to the Lebanese market. These innovative solutions align with our mission to support laboratories with cutting-edge technologies that improve efficiency, diagnostic accuracy, and patient care,” said Leila Macaron, Managing Director, DPC Lebanon.
Visit our websites to learn more:
